Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics to Offer Genetic Testing Through Blue Shield of California's PPO Network

NEW YORK (GenomeWeb News) – Pathway Genomics said today it has joined Blue Shield of California's preferred provider network.

The health insurer has more than 3.3 million members, and its HMO has a network of more than 34,000 doctors and 290 hospitals, while its PPO network has more than 60,000 doctors and 351 hospitals.

Last month, San Diego-based Pathway announced a deal to offer its testing services through Medcan Clinic, Canada's largest private healthcare clinic. The Scripps Center for Executive Health also began offering Pathway's testing services this past fall.

Pathway conducts the analysis and interpretation of test results at its CLIA genetic testing lab.

The firm offers several DNA tests covering diet and exercise, drug response, carrier status, and complex health conditions.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.